Shuttle Pharmaceutical Holdings
Gaithersburg, Maryland, United States · Artificial Intelligence, Biotechnology, Health Care
Shuttle owns a pharmaceutical software AI driven platform for molecular discovery and early-stage drug development. The Molecule.ai platform helps researchers explore the chemical space more efficiently. By combining modern AI techniques with structured workflows, the platform aids in drug development decisions.
Key facts
- Headquarters
- Gaithersburg, Maryland, United States
- Employees
- 23
- Industries
- Artificial Intelligence, Biotechnology, Health Care
- Status
- Public (SHPH)
- Website
- shuttle.dev
- Company page
Recent activity at Shuttle Pharmaceutical Holdings
- : Shuttle Pharmaceuticals acquires United Dogecoin Inc.
- : Shuttle Pharmaceuticals Secures $2.5 Million in Private Placement
- : Shuttle raises $6 million in seed funding to improve vibe-coding deployment, backed by investors like Thomas Dohmke and Calvin French-Owen.
- : Shuttle Pharmaceuticals Holdings
- : Shuttle Pharma Enters into Sponsored Research Agreement with UCSF to Advance PSMA Development Program
- : Shuttle Pharmaceuticals Holdings
- : Shuttle Pharmaceuticals Holdings, Inc. Appoints Timothy Lorber as Chief Financial Officer
- : Shuttle Pharmaceuticals, Inc.
Shuttle Pharmaceutical Holdings funding history
| Date | Round | Amount |
|---|---|---|
| Nov 2025 | Post-IPO Equity | $2.5M |
| Oct 2025 | Seed | $6.0M |
| Jun 2025 | Seed | $4.3M |
| Oct 2024 | Seed | $790K |
| Sep 2016 | Venture | $120K |
Leadership
- Nodar Daneliya, Co-Founder, CEO
- Archie Croft, Founders Associate
- Scott Grindrod, Principle Scientist, Medicinal Chemistry
- Chris Cooper, Chief Executive Officer
- Timothy Lorber, Chief Financial Officer
- Juan Rodriguez Andrade, Chairman
Verified email and direct lines for Shuttle Pharmaceutical Holdings’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Shuttle Pharmaceutical Holdings in the news
- Shuttle Pharmaceuticals Holdings, Inc. Announces Receipt of NASDAQ Noncompliance Letter - Yahoo Finance (Aug 28, 2026)
- United Dogecoin seeks data centers, power assets for DOGE mining and AI - Stock Titan (Jun 25, 2026)
- Shuttle Pharmaceuticals adding cryptocurrency mining with $11M merger deal - The Business Journals (May 01, 2026)
- Design and functions of phospholipid polymer cell shuttles for modern pharmaceutical formulations | Polymer Journal - Nature (Apr 23, 2026)
- United Dogecoin Advances Data Centre and Power Infrastructure Strategy to Support DOGE Mining and AI Hosting - TradingView (Jun 25, 2026)
- RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows - Yahoo Finance (Mar 27, 2026)
- Shuttle Pharmaceuticals Holdings (Nasdaq:SHPH) - Stock Analysis - Simply Wall Street (Sep 03, 2022)
- ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform 'LMT15' - Yahoo Finance (Apr 21, 2026)
Companies similar to Shuttle Pharmaceutical Holdings
- MedReddie · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Medical, Software
- Sophont · Artificial Intelligence, Biotechnology, Health Care, Information Technology, information technology & services, Medical
- Telepatía AI · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Medical, Software
- AKASA · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Medical, Software
- Odysight.ai · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Medical, Software
About Shuttle Pharmaceutical Holdings: questions and answers
What does Shuttle Pharmaceutical Holdings do?
Shuttle owns a pharmaceutical software AI driven platform for molecular discovery and early-stage drug development. The Molecule.ai platform helps researchers explore the chemical space more efficiently. By combining modern AI techniques with structured workflows, the platform aids in drug development decisions.
Where is Shuttle Pharmaceutical Holdings headquartered?
Shuttle Pharmaceutical Holdings is headquartered in Gaithersburg, Maryland, United States.
How many employees does Shuttle Pharmaceutical Holdings have?
Shuttle Pharmaceutical Holdings has about 23 employees.
Has Shuttle Pharmaceutical Holdings raised funding?
Yes. Fundz has recorded 5 funding events for Shuttle Pharmaceutical Holdings. The most recent, Post-IPO Equity of $2.5M, was in Nov 2025.
Who leads Shuttle Pharmaceutical Holdings?
Nodar Daneliya is a Co-Founder, CEO at Shuttle Pharmaceutical Holdings.
What is the latest news on Shuttle Pharmaceutical Holdings?
On May 14, 2026, Shuttle Pharmaceuticals acquires United Dogecoin Inc.
Is Shuttle Pharmaceutical Holdings a public company?
Yes. Shuttle Pharmaceutical Holdings is publicly traded under the ticker SHPH.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy